684 related articles for article (PubMed ID: 20184581)
1. Interobserver variability of clinical scores in hidradenitis suppurativa is low.
Sartorius K; Killasli H; Heilborn J; Jemec GB; Lapins J; Emtestam L
Br J Dermatol; 2010 Jun; 162(6):1261-8. PubMed ID: 20184581
[TBL] [Abstract][Full Text] [Related]
2. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.
Sartorius K; Emtestam L; Jemec GB; Lapins J
Br J Dermatol; 2009 Oct; 161(4):831-9. PubMed ID: 19438453
[TBL] [Abstract][Full Text] [Related]
3. Psychophysical aspects of hidradenitis suppurativa.
Matusiak L; Bieniek A; Szepietowski JC
Acta Derm Venereol; 2010 May; 90(3):264-8. PubMed ID: 20526543
[TBL] [Abstract][Full Text] [Related]
4. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions.
Esmann S; Dufour DN; Jemec GB
Br J Dermatol; 2010 Jul; 163(1):102-6. PubMed ID: 20331444
[TBL] [Abstract][Full Text] [Related]
5. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases.
Wolkenstein P; Loundou A; Barrau K; Auquier P; Revuz J;
J Am Acad Dermatol; 2007 Apr; 56(4):621-3. PubMed ID: 17097366
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis suppurativa markedly decreases quality of life and professional activity.
Matusiak Ł; Bieniek A; Szepietowski JC
J Am Acad Dermatol; 2010 Apr; 62(4):706-8, 708.e1. PubMed ID: 20227585
[No Abstract] [Full Text] [Related]
7. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.
Canoui-Poitrine F; Revuz JE; Wolkenstein P; Viallette C; Gabison G; Pouget F; Poli F; Faye O; Bastuji-Garin S
J Am Acad Dermatol; 2009 Jul; 61(1):51-7. PubMed ID: 19406505
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial.
Pelekanou A; Kanni T; Savva A; Mouktaroudi M; Raftogiannis M; Kotsaki A; Giamarellos-Bourboulis EJ
Exp Dermatol; 2010 Jun; 19(6):538-40. PubMed ID: 19758320
[TBL] [Abstract][Full Text] [Related]
9. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C
J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic study of hidradenitis suppurativa following long-pulsed 1064-nm Nd:YAG laser treatment.
Xu LY; Wright DR; Mahmoud BH; Ozog DM; Mehregan DA; Hamzavi IH
Arch Dermatol; 2011 Jan; 147(1):21-8. PubMed ID: 20855672
[TBL] [Abstract][Full Text] [Related]
11. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.
Grant A; Gonzalez T; Montgomery MO; Cardenas V; Kerdel FA
J Am Acad Dermatol; 2010 Feb; 62(2):205-17. PubMed ID: 20115947
[TBL] [Abstract][Full Text] [Related]
12. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa.
Kamp S; Fiehn AM; Stenderup K; Rosada C; Pakkenberg B; Kemp K; Dam TN; Jemec GB
Br J Dermatol; 2011 May; 164(5):1017-22. PubMed ID: 21250966
[TBL] [Abstract][Full Text] [Related]
13. Hidradenitis suppurativa in the pediatric population.
Liy-Wong C; Pope E; Lara-Corrales I
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
[TBL] [Abstract][Full Text] [Related]
14. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
[TBL] [Abstract][Full Text] [Related]
15. Depression in patients with hidradenitis suppurativa.
Onderdijk AJ; van der Zee HH; Esmann S; Lophaven S; Dufour DN; Jemec GB; Boer J
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):473-8. PubMed ID: 22339940
[TBL] [Abstract][Full Text] [Related]
16. Infliximab for the treatment of hidradenitis suppurativa.
Fernández-Vozmediano JM; Armario-Hita JC
Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
[TBL] [Abstract][Full Text] [Related]
17. Hidradenitis suppurativa.
Revuz J
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):985-98. PubMed ID: 19682181
[TBL] [Abstract][Full Text] [Related]
18. New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes.
van der Zee HH; Jemec GB
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S23-6. PubMed ID: 26470610
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
Gener G; Canoui-Poitrine F; Revuz JE; Faye O; Poli F; Gabison G; Pouget F; Viallette C; Wolkenstein P; Bastuji-Garin S
Dermatology; 2009; 219(2):148-54. PubMed ID: 19590173
[TBL] [Abstract][Full Text] [Related]
20. Painful hidradenitis suppurativa.
Smith HS; Chao JD; Teitelbaum J
Clin J Pain; 2010 Jun; 26(5):435-44. PubMed ID: 20473053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
